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Abstract
The seeds of Moringa stenopetala which are known to be rich sources of glucosinolates, primarily glucomoringin,
have been shown to have limited anticancer effects when tested in vitro. In the present study, however, the water
extract of the seeds obtained following defatting by hexane displayed potent cytotoxic activity against HepG2 (IC50,
6.28 ± 0.55 µg/ml) and the SH-SY5Y human neuroblastoma (IC50, 9.81 ± 1.30 µg/ml) cells. The methanol extract
displayed a weak cytotoxic activity against the HepG2 human hepatocellular cancer cells when tested upto 500
µg/ml, while extraction with hexane yielded the non-cytotoxic fixed oil which fatty acid composition was primarily
oleic acid (75%). By monitoring the constituents of the water extract by HPLC and a one-step combiflash
chromatographic system using C-18 silica gel system, the principal active constituent (glucomoringin isothiocyanate
or moringin; 4(α-L-rhamnosyloxy)-benzyl isothiocyanate) was isolated. Moringin was 6.3 and 2.4 times more potent
than etoposide in the HepG2 and SH-Sy5Y cell lines respectively. The isolation of this potent potential anticancer
compound from the seeds of M. stenopetala without the need for multi-step chromatographic and enzyme-digestion-
based purification steps are discussed.
Keywords: Moringa stenopetala; Moringaceae; Seeds;
Glucomoringin isothiocyanate; Moringin; Cancer; HPLC; Combiflash
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Introduction
Moringa stenopetala, also called the African Moringa is native to the
Southern region of Ethiopia and Northern Kenya. The plant has
multipurpose usage that mirrors the well-known Moringa, M. oleifera,
commonly known as the Indian Moringa. Being described as “The
Miracle Tree”, the plant is used as a source of food to humans and as
animal fodder, medicine, edible oils, biofuel and applications for water
sanitations [1,2]. The various parts of M. stenopetala are extensively
employed in the Ethiopian and Kenyan traditional medicine for
treating a range of illnesses such as, diabetes, hypertension, stomach
pain, malaria, leishmaniasis, leprosy, epilepsy, diarrhoea, asthma,
colds, as an anthelmintic, emetic and wound healing [3]. Some of the
recent pharmacological studies that appear to validate the claimed
medicinal uses of the plant, primarily the leaves, include antimicrobial
[4,5], antihypertensive [6-8], and blood glucose lowering and other
favourable blood biochemical parameters [1,2,6,9-13].
The seeds of M. stenopetala are packed full of fixed oils (over 30%
by weight) which are characterised by the predominant oleic acid
(around 75%) composition [14,15]. The seeds are also sources of the
cationic proteins which are responsible for the flocculant activity
and/or water purification potential of the plant [16,17]. The secondary
metabolites of the seeds are represented by glucosinolates primarily
glucomoringin (GMG; 4(α-L-rhamnosyloxy)-benzyl glucoseinolate, 1;
Figure 1) which is reported to constitute about 13% of the seeds by dry
weight [18]. Plants producing glucosinolates are also equipped with a
thio-linked glucose hydrolysis enzyme called myrosinase
(thioglucoside glucohydrolase, EC 3.2.3.1) that liberate bioactive
molecules such as isothiocyanates and nitriles and in the case Moringa,
the principal enzyme hydrolysis product in the seeds is 4(α-L-
rhamnosyloxy)-benzyl isothiocyanate (GMG-ITC) or moringin
(Figure 1). To date, moringin obtained through enzyme catalyzed
extraction process from plants such as M. oleifera has been shown to
have numerous pharmacological effects including as chemoprotective
agent against cancer progression and direct antitumoural effects along
with antioxidant and antiinflammatory properties both in vitro and in
vivo [19-25]. Despite all these established pharmacology for moringin
(2), the anticancer potential of M. stenopetala seeds has not been
established and preliminary study on the methanol extract has shown
effect only at high doses (500 µg/ml) in vitro when tested against the
HepG2 hepatocytes cell line [26]. Since, such a weak effect shown for
the seeds was suspected to be due to the methodology of extraction
employed, the organic extracts with high oil content masking/diluting
the active principles, the present study was undertaken to demonstrate
the anticancer potential of the seeds and isolation of the active
principle(s).
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Figure 1: Structures of glucomoringin its isothiocyanate derivative, moringin.
Materials and Methods
Chemicals
All solvents used for the extraction and chromatographic analysis
were obtained from Fisher Scientific UK Ltd (Loughborough, UK)
while all other reagents were from Sigma (Sigma-Aldrich Chemical
Company, Dorset, UK).
Extraction of the plant material
The seeds of M. stenopetala were purchased from Ethiopian supplier
as described previously [1,2]. The seeds were crushed and made into
small pieces and extracted at room temperature by either methanol or
successively by hexane followed by water. In each case, the plant
material (20 g) was soaked in the chosen solvent (1 L) and left
overnight. After removing the extract, the remaining plant material
was further extracted twice with the same solvent to maximize the
yield. The bulked extracted materials labelled as methanol, hexane, and
water are taken for bioassays and further chromatographic analysis.
In vitro anticancer activity evaluations
The liver hepatocellular HepG2 and SH-SY5Y neuroblastoma cell
cultures were obtained from the European Collection of Cell Cultures
(Public Health England, Porton Down, Salisbury, UK). Cell cultures
were routinely maintained with RPMI 1640 medium supplemented
with 10% heat inactivated foetal bovine serum, 50 IU/ml penicillin and
50 μg/ml streptomycin in a humidified atmosphere of 95% air-5% CO2
at 37 °C. Cells were seeded in 96-well plates at a density of 5,000 cells
per well and allowed to establish by incubating plates for 24 h. Various
concentrations of the test compounds were then added and culture
plates were further incubated for 24 h. Cell viability was assessed by
measuring the fluorescence of Alamar Blue as described previously
[27].
Isolation and structural assignments of compounds
Isolation: The RediSep C18 gold column (100 g, Presearch,
Hampshire, UK) attached to a Teledyne Isco flash chromatography
system was used to isolate moringin from the water extract of M.
stenopetala seeds. The solvent system was composed of methanol and
water: a linear gradient started from 10% methanol to 100% over a
period of 25 minutes was employed. The flow rate was maintained at
60 ml/min and the chromatogram was monitored by using dual
wavelength of 214 and 254 nm. Through this methodology, analysis of
3.9 g of the extract yielded 30 mg of pure moringin.
HPLC analysis: The HPLC analysis was based on an Agilent 1200
series gradient system composed of degasser (G1322A), quaternary
pump (G1322A), auto sampler (G1329A), thermostat column
compartment (G1316A) maintained at 25oC and a diode array detector
(G1315D). Test samples were injected (20 µL) into a reverse phase
column (Agilent - Eclipse XDB-C18, 5 µm, 4.6 x 150 mm) and eluted
with the mobile phase which was a mixture of water (A) and methanol
(B). The composition of the mobile phase at a flow rate of 1 ml/min
was rising from 10% to 90% B over a period of 50 minutes.
General analytical instrumentation and methodology: 1H NMR, 13C
NMR and 2D-NMR (HMQC and HMBC) spectra were obtained on a
JEOL 500 MHz instrument. Homonuclear 1H connectivities were
determined by using the COSY experiment. One bond 1H-13C
connectivities were determined with HMQC while two- and three-
bond 1H-13C connectivities were determined by HMBC experiments.
Chemical shifts were reported in δ (ppm) using the solvent (Dimethyl
sulfoxide-D6) standard. The High resolution mass spectroscopy
instrument, Thermofisher LTQ Orbitrap XL (Thermofisher Scientific,
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UK), with an electrospray ionisation probe was used for accurate mass
measurement over the full mass range of m/z 50-2000. Nano-
electrospray analyses were performed in positive ionization mode by
using NanoMate to deliver samples diluted into MeOH+10%
NH4OAc. The temperature was set at 200oC, sheath gas flow of 2 units
and capillary (ionizing) voltage at 1.4 kV. The accurate mass
measurements obtained from this system were far better than 3 ppm.
GC-MS analysis: The fatty acid composition of seeds of M.
stenopetala has been described previously [14,15]. Briefly, the fatty
acid methyl ester derivatives of the seed oil obtained from the hexane
extract was analysed by GC-MS using the Perkin Eilmer TurboMass
spectrometer coupled with PE AutoSytem XL GC chromatography.
The operating parameters were as follow: Column: Spec-DB-5MS
(Length 30 metre and ID of 0.25 mm), Carrier gas: helium, flow rate: 1
ml/min, inlet temp: 250oC, Detector temp: 280oC, with temperature
programming of 120-240 oC over 40 min and library search from the
NIST spectral database.
Moringin (2): Colourless gummy powder; UV (MeOH) λmax nm:
223, 264 (sh); IR (Universal Attenuated Total Reflectance) νmax; 3339
(br; OH), 2932, 2169, 2082, 1612, 1589, 1509, 1239, 1119, 1098, 1059,
1014, 980 cm-1; 1H and 13C NMR (MeO-D4): (Table 1) ESI-MS m/z [M
+NH4]+ 329.1169 (calc C14H17NO5SNH4 329.1166); 337.0732
observed for [M+Na]+, C14H17NO5SNa, (theoretical, 334.0720).
Statistical analysis
All cytotoxic measurements were carried out at least in
quadruplicate set up and repeated at least four times. Results are
shown as mean ± standard error of mean (SEM). Where necessary,
unpaired student t-test was employed to assess significant differences
between two mean values.
Results and Discussion
As part of our attempt to identify potential anticancer agents from
natural sources, our laboratories have been investigating numerous
crude and purified plant secondary metabolites [28-36]. The present
study focused on the seeds of a plant which has been extensively
advocated as a safe alternative means of flocculent agent for water
purification and also sources of edible oil that could also be exploited
as biofuel. The therapeutic potential of the leaves and seeds of M.
stenopetala along with the socioeconomic significance of the plant
have been the subject of intense scrutiny in recent years [3].
Despite the established presence of glucomoringin (1) in M.
stenopetala seeds, the in vitro anticancer effect of the extracts of the
seeds has been reported to be weak and manifested at high doses when
tested against the HepG2 hepatocyte cell line [26]. On the other hand,
the prevalent pharmacological activity of glucosinolates has been
shown to be associated with the generation of more biologically active
compounds, isothiocyanates, through action by the myrosinase
enzyme. Hence, the large scale biological activity assessments of
moringin (2) from M. oleifera seeds and other sources have been based
on the isolation of the compound through enzyme-hydrolyzed
extraction procedures. This involve several steps: first, the parent
glucosinolate, glucomoringin (1), has to be purified from the seeds
through sequential chromatographic steps such as isolation through
anion exchange system followed by gel filtration chromatography.
Moringin (2) is then produced through a hydrolysis reaction by using `
sourced from other plant species (e.g. from seeds of Sinapis alba
[22,23]. It is herein demonstrated that these steps are not necessary to
obtain the bioactive product moringin (2) from the seeds of M.
stenopetala.
Extraction of the seeds of M. stenopetala by methanol gave the
crude extract in the yield of 32% while extraction with hexane followed
by water yielded 28.4 and 15% respectively. In order to reproduce the
results already reported on the possible cytotoxicity of M. Stenopetala
seeds against cancer cells, the same cell line (HepG2) was used for the
initial assessment. As shown in Figure 2, the methanol extract was very
week showing marginal activity at the highest concentration tested.
Considering that around 30% of the seeds by weight constitute fixed
oils with oleic acid as predominant but also other fatty acids
composition [14,15], any biologically active compound present in the
seeds is likely to be diluted by the oils and hence its biological activity
could be masked. The other explanation for the weak biological activity
of the methanol extract could be due to the fact that glucosinolates
may not be as active as their highly potent derivatives isothiocyanates;
the latter of which require enzymatic action to be liberated from their
parent compounds (glucosinolates).
When the seeds of M. stenopetala were first extracted with hexane
and then by water, instead of the common alcoholic extraction, a
completely different profile of biological activity was observed. The
hexane extract which is a source of fixed oil did not show cytotoxicity
against cancer cells as expected up to the concentration of 500 µg/ml
(Figure 2). The compositional analysis of the hexane extract by GC-MS
also reveal the classical components consistent with what has already
been reported for this plant [14,15]: Oleic acid (75.2%); palmitic acid
(6.5); stearic acid (9.1); 7(Z)-hexadecanoic acid (2.1); arachidonic acid
(4.6) and behenic acid (0.6%). The focus of isolating potential
anticancer agent(s) from the seeds of M. stenopetala was thus centered
in the defatted water extract of the seeds.
Figure 2: Cytotoxicity of the seeds extract of M. stenopetala against
HepG2 cells. Notice that, when the seeds extract was first defatted
by hexane followed by water extraction, the latter showed potent
potential anticancer activity.
The components of the water extract of M. stenopetala seeds that
was obtained through water extraction following defatting by hexane
were monitored by HPLC. As shown in Figure 3, the HPLC
chromatogram shows uncomplicated profile with one major
components apparent through both UV detectors (215 and 280 nm)
employed. The highly polar components such as glucosinolates,
carbohydrates and proteins are normally eluted within the first 10 min
while the isothiocyanates such as moringin (2) are nonpolar
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components that are eluted later in the chromatographic analysis.
Large scale extraction/isolation of compounds from water interface
complex mixtures of crude natural products is always a challenge. First,
the HPLC chromatogram of the water fraction (Figure 3) deceptively
appears to be uncomplicated as only UV detectable compounds in the
seeds that is packed full of sugars and inorganic materials in water
medium are visible. Secondly, the HPLC system is really a quantitative
method and does not represent a reliable means of natural products
isolation on preparative scale. My laboratory effectively employ the
Combiflash chromatographic system for the large scale isolation of
biologically active natural products; including flavonoids from the
leaves of the same plant, M. stenopetala [1,2]. Through just one-step
procedure using a reverse phase silica gel flash chromatography system
(Figure 4), the known biologically active compound, moringin (2) that
corresponds to the retention time of 33.6 min in Figure 3, was isolated
in good yield. Hence, the routine procedure of isolation of moringin
(2) from M. oleifera or other plant sources through ion exchange and
other chromatographic methods followed by enzyme catalyzed
reaction appears to be unnecessary for obtaining this isothiocyanate
compound from M. stenopetala seeds. The incredibly potent activity
shown for the crude extract of M. stenopetala seeds when extracted
under the method described herein also suggest that the plant could
probably be developed as a cheap source of anticancer agent without
even the need to isolate the active principle in its purest form.
Figure 3: HPLC profile of the water extract obtained after defatting
the seeds of M. stenopetala with hexane extraction. The water
extract (5 mg/ml in methanol) was analysed by HPLC as describe in
the materials and methods section.
Figure 4: Combiflash chromatographic profile of the water fraction. Experiments are carried out as described in the materials and methods
section. The preparative scale isolation of moringin is shown.
The identification of the isolated product as moringin (2) was based
on comprehensive 2-D NMR studies including COSY, HMBC, HMQC
as well as 1-D NMR (1H, 13C NMR and dept 13C NMR analysis)
experiments. The NMR data were generally in good agreement with
those already published for 4(α-L-rhamnosyloxy)-benzyl
isothiocyanate [37]. The data herein was however obtained by using
methanol-D4 instead of CDCl3 [37] and hence presented in full (Table
1) to benefit the readers. Accurate mass analysis also allowed to
confirm the structure as the [M + Na]+ and [M + NH4]+ ions were in
perfect agreement with those expected for the compound (see
experimental section).
The activity of the crude extract and the isolated bioactive principle
were tested for their anticancer effect in vitro with due comparison
with a known clinically useful drug, etoposide. These data on HePG2
and SH-SY5Y neuroblastoma cells are shown in Table 2. It appears that
the crude extract obtained by water was a potent anticancer agent with
slightly less activity than etoposide. On the other hand, the purified
active principle isolated from the water extract, moringin (2), was
about 5 and 8 times more potent than the crude extract in the
hepatocyte and neuroblastoma cell lines respectively. In these cell lines,
moringin (2) was also far superior to etoposide as anticancer agent in
vitro (Table 2). On molar basis, for example, moringin (2) was 6.3 and
2.4 times more potent than etoposide in the HepG2 and SH-Sy5Y cell
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lines respectively. The seeds of M. stenopetala could thus be used as a
good source of a potent potential anticancer agent, moringin (2) that is
currently obtained through various chromatographic methods of
isolation coupled with enzymatic digestions.
Position δH δC Key 3J HMBC Correlations
Aromatic
1 - 130.1 -
2, 6 7.27 d (8.7) 129.6 48.2, 117.6, 157.8
3, 5 7.07 d (8.7) 117.6 129.6, 157.8
4 - 157.8 -
-CH2- 4.67s 48.2 130.0, 130.1
N=C=S - 130.3 -
Sugar
1’ 5.42 d (1.85) 99.8 70.6, 157.8
2’ 3.99 dd (3.2, 1.85) 72 72.2, 73.8,
3’ 3.82 dd (9.6, 3.65) 72.2 72.0, 73.8
4’ 3.45 t (9.6) 73.8 17.5, 70.6, 72.0, 72.2
5’ 3.61 m 70.6 -
6’ 1.2 (6.4) 17.5 70.6, 73.8
Table 1: 1H, 13C and 3J HMBC NMR data for Moringin. All
experiments were run in CD3OD - δ values in ppm and coupling
constant (J) in parenthesis are shown.
With IC50 value between 1-10 µM [38-40], the SH-SY5Y cells are
generally known to be more sensitive to etoposide than HePG2 cells. In
the latter case, etoposide has been shown to display activity with IC50
value around 30.0 µM [41,42]. Hence, the biological effect recorded for
the positive control etoposide in the present study (Table 2) was in
good agreement with previous reports. On the other hand,
concentrations of moringin (2) higher than 12 μM have been shown to
be effective in inducing apoptosis in human malignant astrocytoma
cells through p53 and Bax activation and Bcl-2 inhibition [22]. The
oxidative stress related Nrf2 transcription factor and its upstream
regulator CK2 alpha expressions were also shown to be modulated at
higher doses of moringin. At the same time, a significant reduction in
5S rRNA was observed with moringin (2) treatment [23]. Brunelli et al.
[43] have also conducted in vitro and in vivo experiments on moringin
(2). By inhibiting NF-kB activity and inducing apoptosis through a
caspase-dependent pathway, moringin (2) has been shown to display
anticancer activity in a myeloma model, both in vitro and in vivo [43].
As sown in Table 2, moringin also appear to be more potent than the
clinically used drug etoposide further highlighting the anticancer
potential of M. stenopetala seeds either in the crudest form or as
source of moringin through the method of isolation described in the
present study. Given the antitumour activity of moringin (2) has
already been established in the last three years and the compound
appears to be the major principle of M. stenopetala seeds, there was no
need to undertake more experiments to establish the anticancer
potential of the plant.
 IC50 values: µg/ml (µM)  
 HepG2 SH-SY5Y
Methanol extract >500 >500
Hexane extract >500 >500
Water extract of the defatted seeds 6.28 ± 0.55 (n=4) 9.81 ± 1.30 (n=7)
Moringin 1.21 ± 0.24* (3.90 ± 0.78)*(n=4) 1.23 ± 0.16* (3.39 ± 0.57)* (n=5)
Etoposide 14.50 ± 1.85 (24.65 ± 3.14) (n=4) 5.75 ± 0.16 (7.98 ± 2.12) (n=4)
Table 2: Cytotoxicity of extracts and seeds of M. stenopetala, the active principle (moringin, 2) and etoposide against cancer cells in vitro. *
Indicate data was significantly different from the etoposide treatment in the same cell line (p<0.01).
Conclusion
The present study highlighted that the seeds of M. stenopetala has
tremendous potential as anticancer agent if it is defatted first by non-
polar extract before extraction with aqueous media. The active
principle, moringin which was obtained from other sources and
showed promising anticancer effect in various experimental models,
could also be isolated from M. stenopetala seeds without the need to go
through lengthy processes of purification coupled with enzyme-
assisted glucosinolate degradation methods.
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